Mindfulness Training for Staff (MTS)

计划入组 53 人 · 首次发布于 2010 年 3 月 8 日

Postmarketing Clinical Study on AO-128

计划入组 197 人 · 首次发布于 2014 年 11 月 10 日

Efficacy and Safety Study of TAK-128 in Treating Subjects With Diabetic Peripheral Neuropathy

计划入组 343 人 · 首次发布于 2005 年 9 月 29 日

MTS-008

MTS-105

MTS-201

SYNCORE BIOTECHNOLOGY CO., LTD.

Taiwan

Savient Pharmaceuticals, Inc.

United States

TAIRX, INC.

Taiwan

METiS TechBio Licenses AI-Designed Trispecific T-Cell Engager MTS-128 to Boulevard Bio in Deal Worth Up to $1.6 Billion

METiS TechBio's AI-Designed Drug MTS-004 Becomes First in China to Complete Phase III Trial for Pseudobulbar Affect

METiS TechBio Advances mRNA Cancer Therapeutics with Dual Publications in Nature Communications and JITC